Tocilizumab Biosimilar
Bio‑Thera Expands Tocilizumab Biosimilar Reach Through STADA Partnership
Chinese biotech Bio‑Thera partners with STADA to commercialize BAT1806, a tocilizumab biosimilar, in Europe, UK, Switzerland, MENA, and CIS regions. The deal reinforces Bio‑Thera’s international growth strategy and biosimilar pipeline.